John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$172M |
| 2 |
Johnson & Johnson
JNJ
|
+$161M |
| 3 |
American Express
AXP
|
+$161M |
| 4 |
Apple
AAPL
|
+$156M |
| 5 |
Emerson Electric
EMR
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$172M |
| 2 |
AGN
Allergan Inc
AGN
|
+$139M |
| 3 |
Wynn Resorts
WYNN
|
+$111M |
| 4 |
AbbVie
ABBV
|
+$94.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$94.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 14.92% |
| 2 | Technology | 11.5% |
| 3 | Industrials | 10.9% |
| 4 | Healthcare | 10.87% |
| 5 | Consumer Staples | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
Williams Companies
WMB
$86.8B
| $438K | ﹤0.01% |
+8,660
| New | +$401K |
|
|
ALR
2052
DELISTED
AlerisLife Inc
ALR
| $438K | ﹤0.01% |
9,876
-1,522
| -13% | -$57.4K |
|
2053
PUT
Franco-Nevada
FNV
$52.1B
| $437K | ﹤0.01% |
+9,000
| New | +$468K |
|
2054
PUT
Goodyear
GT
$1.73B
| $433K | ﹤0.01% |
+16,000
| New | +$418K |
|
|
FARM
2055
DELISTED
Farmer Brothers
FARM
| $431K | ﹤0.01% |
+17,396
| New | +$464K |
|
2056
JPMorgan Chase
JPM
$947B
| $431K | ﹤0.01% |
7,120
-945,397
| -99% | -$56M |
|
2057
Hilltop Holdings
HTH
$2.22B
| $430K | ﹤0.01% |
+22,124
| New | +$421K |
|
|
PRGX
2058
DELISTED
PRGX Global, Inc.
PRGX
| $430K | ﹤0.01% |
106,866
+18,935
| +22% | +$92.9K |
|
2059
CALL
Kimberly-Clark
KMB
$37B
| $428K | ﹤0.01% |
+4,000
| New | +$442K |
|
2060
PUT
PVH
PVH
$3.55B
| $426K | ﹤0.01% |
+4,000
| New | +$433K |
|
|
TXNM
2061
TXNM Energy Inc
TXNM
$5.88B
| $425K | ﹤0.01% |
14,551
-5,860
| -29% | -$171K |
|
|
ZIXI
2062
DELISTED
Zix Corporation
ZIXI
| $424K | ﹤0.01% |
107,819
-22,297
| -17% | -$84.5K |
|
2063
Illinois Tool Works
ITW
$80.9B
| $423K | ﹤0.01% |
4,354
-20,029
| -82% | -$1.93M |
|
|
LF
2064
DELISTED
LEAPFROG ENTERPRISES INC.
LF
| $423K | ﹤0.01% |
194,088
+1,686
| +0.9% | +$4.81K |
|
2065
PUT
Boston Properties
BXP
$11.2B
| $421K | ﹤0.01% |
+3,000
| New | +$419K |
|
2066
UNIFI
UFI
$142M
| $421K | ﹤0.01% |
11,656
-8,149
| -41% | -$266K |
|
|
NP
2067
DELISTED
Neenah, Inc. Common Stock
NP
| $421K | ﹤0.01% |
+6,728
| New | +$403K |
|
|
NEWP
2068
DELISTED
NEWPORT CORP
NEWP
| $421K | ﹤0.01% |
22,080
-21,625
| -49% | -$418K |
|
|
MBLY
2069
PUT
DELISTED
Mobileye N.V.
MBLY
| $420K | ﹤0.01% |
+10,000
| New | +$389K |
|
|
MIG
2070
DELISTED
MEADOWBROOK INSURANCE GRP INC
MIG
| $420K | ﹤0.01% |
49,383
-4,810
| -9% | -$40.3K |
|
2071
PUT
Core Laboratories
CLB
$553M
| $418K | ﹤0.01% |
+4,000
| New | +$426K |
|
2072
PUT
Eagle Materials
EXP
$6.27B
| $418K | ﹤0.01% |
+5,000
| New | +$389K |
|
|
OHAI
2073
DELISTED
OHA Investment Corporation
OHAI
| $418K | ﹤0.01% |
79,303
-41,963
| -35% | -$203K |
|
2074
Natural Gas Services Group
NGS
$448M
| $417K | ﹤0.01% |
21,687
-10,533
| -33% | -$209K |
|
2075
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
| $416K | ﹤0.01% |
+1,500
| New | +$404K |
|
Similar funds
John Overdeck's Q1 2015 Portfolio in Review
As of Q1 2015, John Overdeck held 3,174 positions worth $21.5B, up 19% from $18.1B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
John Overdeck deployed $3.03B of net new capital in Q1 2015, opening 981 new positions and adding to 805 existing holdings. Its largest new stake was Intel: 5,084,443 shares worth $159M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 15% of assets, up from 10% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was AbbVie, an estimated $94.4M trimmed.
- John Overdeck's largest Q1 2015 buy was Intel: 5,084,443 shares worth $159M.
- John Overdeck added most to Johnson & Johnson in Q1 2015, an estimated $161M increase.
- John Overdeck's biggest Q1 2015 reduction was AbbVie, cutting an estimated $94.4M.
- John Overdeck fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q1 2015, selling an estimated $172M.
- John Overdeck's ten largest holdings make up 7.3% of its $21.5B portfolio in Q1 2015.
- John Overdeck opened 981 new positions and closed 576 in Q1 2015.
- John Overdeck's portfolio value rose 19% quarter-over-quarter to $21.5B.
Based on Two Sigma Investments's 13F filing for Q1 2015, filed 15 May 2015.